Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Douglas

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of Personalized Medicine|April 23, 2022
Analyzing Precision Medicine Utilization with Real-World Data: A Scoping ReviewMichael P Douglas, Anika Kumar
The Journal of Precision Medicine|March 10, 2020
The Global Market for Next-Generation Sequencing Tests Continues Its Torrid PaceKathryn A Phillips, Michael P Douglas
Substance Use & Addiction Journal|March 28, 2026
Meeting Veterans Where They Are: Harm Reduction Supply Distribution via Vending MachinesTessa Rife-Pennington, Wendy Xie, Michael P Douglas
Health Affairs (Project Hope)|March 7, 2022
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient AccessPatricia A Deverka, Michael P Douglas, Kathryn A Phillips
JAMA|October 26, 2020
Expanding Use of Clinical Genome Sequencing and the Need for More Data on ImplementationKathryn A Phillips, Michael P Douglas, Deborah A Marshall
Substance Use & Misuse|February 11, 2026
Pharmacist-Led Fentanyl Test Strip Education and Distribution for Veterans in Substance Use Treatment: A Quality Improvement ProjectTessa Rife-Pennington, Michael P Douglas, David L Pennington
JAMA|May 31, 2019
Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional LabsKathryn A Phillips, Julia R Trosman, Michael P Douglas
The Journal of Liquid Biopsy|April 20, 2026
The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling studyJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019Michael P Douglas, Stacy W Gray, Kathryn A Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2025
Combining simulation model-based outcomes with county-level data for geographic health equity impact evaluations of new interventionsJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of Personalized Medicine|April 23, 2022
Analyzing Precision Medicine Utilization with Real-World Data: A Scoping ReviewMichael P Douglas, Anika Kumar
The Journal of Precision Medicine|March 10, 2020
The Global Market for Next-Generation Sequencing Tests Continues Its Torrid PaceKathryn A Phillips, Michael P Douglas
Substance Use & Addiction Journal|March 28, 2026
Meeting Veterans Where They Are: Harm Reduction Supply Distribution via Vending MachinesTessa Rife-Pennington, Wendy Xie, Michael P Douglas
Health Affairs (Project Hope)|March 7, 2022
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient AccessPatricia A Deverka, Michael P Douglas, Kathryn A Phillips
JAMA|October 26, 2020
Expanding Use of Clinical Genome Sequencing and the Need for More Data on ImplementationKathryn A Phillips, Michael P Douglas, Deborah A Marshall
Substance Use & Misuse|February 11, 2026
Pharmacist-Led Fentanyl Test Strip Education and Distribution for Veterans in Substance Use Treatment: A Quality Improvement ProjectTessa Rife-Pennington, Michael P Douglas, David L Pennington
JAMA|May 31, 2019
Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional LabsKathryn A Phillips, Julia R Trosman, Michael P Douglas
The Journal of Liquid Biopsy|April 20, 2026
The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling studyJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019Michael P Douglas, Stacy W Gray, Kathryn A Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2025
Combining simulation model-based outcomes with county-level data for geographic health equity impact evaluations of new interventionsJeroen P Jansen, Michael P Douglas, Kathryn A Phillips
Pageof 7